Literature DB >> 29112887

Comparative performance analysis of human iPSC-derived and primary neural progenitor cells (NPC) grown as neurospheres in vitro.

Maxi Hofrichter1, Laura Nimtz1, Julia Tigges1, Yaschar Kabiri1, Friederike Schröter2, Brigitte Royer-Pokora3, Barbara Hildebrandt3, Martin Schmuck1, Alexey Epanchintsev4, Stephan Theiss5, James Adjaye2, Jean-Marc Egly4, Jean Krutmann6, Ellen Fritsche7.   

Abstract

Developmental neurotoxicity (DNT) testing performed in rats is resource-intensive (costs, time, animals) and bears the issue of species extrapolation. Thus, reliable alternative human-based approaches are needed for predicting neurodevelopmental toxicity. Human induced pluripotent stem cells (hiPSCs) represent a basis for an alternative method possibly being part of an alternative DNT testing strategy. Here, we compared two hiPSC neural induction protocols resulting in 3D neurospheres: one using noggin and one cultivating cells in neural induction medium (NIM protocol). Performance of Nestin+/SOX2+ hiPSC-derived neural progenitor cells (NPCs) was compared to primary human NPCs. Generally, primary hNPCs first differentiate into Nestin+ and/or GFAP+ radial glia-like cells, while the hiPSC-derived NPCs (hiPSC-NPC) first differentiate into βIII-Tubulin+ neurons suggesting an earlier developmental stage of hiPSC-NPC. In the 'Neurosphere Assay', NIM generated hiPSC-NPC produced neurons with higher performance than with the noggin protocol. After long-term differentiation, hiPSC-NPC form neuronal networks, which become electrically active on microelectrode arrays after 85days. Finally, methylmercury chloride inhibits hiPSC-NPC and hNPC migration with similar potencies. hiPSC-NPCs-derived neurospheres seem to be useful for DNT evaluation representing early neural development in vitro. More system characterization by compound testing is needed to gain higher confidence in this method.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain development; In vitro; MEA; Stem cell; Testing

Mesh:

Year:  2017        PMID: 29112887     DOI: 10.1016/j.scr.2017.10.013

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  25 in total

1.  Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis.

Authors:  Julia Deinsberger; David Reisinger; Benedikt Weber
Journal:  NPJ Regen Med       Date:  2020-09-11

2.  Anchoring a dynamic in vitro model of human neuronal differentiation to key processes of early brain development in vivo.

Authors:  Susanna H Wegner; Julie Juyoung Park; Tomomi Workman; Sanne A B Hermsen; Jim Wallace; Ian B Stanaway; Hee Yeon Kim; William C Griffith; Sungwoo Hong; Elaine M Faustman
Journal:  Reprod Toxicol       Date:  2019-11-16       Impact factor: 3.143

3.  Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Authors:  Sarah Logan; Thiago Arzua; Scott G Canfield; Emily R Seminary; Samantha L Sison; Allison D Ebert; Xiaowen Bai
Journal:  Compr Physiol       Date:  2019-03-14       Impact factor: 9.090

Review 4.  Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models.

Authors:  Katya D'Costa; Milena Kosic; Angus Lam; Azeen Moradipour; Yimu Zhao; Milica Radisic
Journal:  Ann Biomed Eng       Date:  2020-04-13       Impact factor: 3.934

5.  A human stem cell-derived test system for agents modifying neuronal N-methyl-D-aspartate-type glutamate receptor Ca2+-signalling.

Authors:  Stefanie Klima; Markus Brüll; Anna-Sophie Spreng; Ilinca Suciu; Tjalda Falt; Jens C Schwamborn; Tanja Waldmann; Christiaan Karreman; Marcel Leist
Journal:  Arch Toxicol       Date:  2021-03-13       Impact factor: 5.153

6.  Nanoarchitectonics of a Microsphere-Based Scaffold for Modeling Neurodevelopment and Neurological Disease.

Authors:  Eric S Sandhurst; Sharad V Jaswandkar; Krishna Kundu; Dinesh R Katti; Kalpana S Katti; Hongli Sun; Daniel Engebretson; Kevin R Francis
Journal:  ACS Appl Bio Mater       Date:  2022-01-19

Review 7.  Brain organoids: A promising model to assess oxidative stress-induced central nervous system damage.

Authors:  Foluwasomi A Oyefeso; Alysson R Muotri; Christopher G Wilson; Michael J Pecaut
Journal:  Dev Neurobiol       Date:  2021-05-18       Impact factor: 3.102

Review 8.  Recent trends in stem cell-based therapies and applications of artificial intelligence in regenerative medicine.

Authors:  Sayali Mukherjee; Garima Yadav; Rajnish Kumar
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

9.  Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis.

Authors:  Julia Deinsberger; David Reisinger; Benedikt Weber
Journal:  NPJ Regen Med       Date:  2020-09-11

10.  Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.

Authors:  Anna Bal-Price; Francesca Pistollato; Magdalini Sachana; Stephanie K Bopp; Sharon Munn; Andrew Worth
Journal:  Toxicol Appl Pharmacol       Date:  2018-02-22       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.